Cervical Cancer

News Cervical Cancer

• Moffitt researchers analyze HPV vaccination disparities among girls from low-income families

  Researchers at Moffitt Cancer Center and colleagues at the University of Florida studied health care providers to determine the factors associated with disparities in Human Papillomavirus (HPV) vaccination among girls, ages 9 to 17, from low-income families. They found that physician vaccination str more

• More parents say they won't vaccinate daughters against HPV, researchers find

  A rising percentage of parents say they won't have their teen daughters vaccinated to protect against the human papilloma virus, even though physicians are increasingly recommending adolescent vaccinations, a study by Mayo Clinic and others shows. More than 2 in 5 parents surveyed believe the HPV va more

• Queen's University Belfast makes significant cancer breakthrough

  A major breakthrough by scientists at Queen's University Belfast could lead to more effective treatments for throat and cervical cancer. The discovery could see the development of new therapies, which would target the non-cancerous cells surrounding a tumour, as well as treating the tumour itself.Re more

Publications Cervical Cancer

• Heparin increases the infectivity of Human Papillomavirus Type 16 independent of cell surface proteoglycans and induces L1 epitope exposure

  Summary Human Papillomaviruses (HPVs) are the etiological agents of cervical cancer, and HPV‐16 is the most prevalent type. Several HPVs require heparan sulfate proteoglycans (HSPGs) for cell‐binding. Here, we analyze the phenomenon that preincubation of HPV‐16 with increasing concentrations of more

• Dried cervical spots for human papillomaviruses identification

  Abstract Financial and operational constraints limit low‐resource countries in the screening of high‐risk genital human papillomaviruses (HR‐HPV), the etiological agents of cervical cancer. With its simple storage, conservation and shipping, dried cervical sample (DCS) could represent an efficie more

• Treatment results of incomplete chemoradiotherapy in locally advanced cervical cancer

  Gao Y, Gao F, Liu Z, Song LP more

Market studies Cervical Cancer

• Iran Pharmaceuticals and Healthcare Report Q2 2012

  BMI View: We continue viewing Iran as one of the less attractive regional markets. Imposition of more stringent international sanctions, rampant inflation, and the loss of confidence in the Iranian rial weigh heavily on consumption and investment patterns, and also on government revenues and the aut more

• Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline

  GBI Research, the leading business intelligence provider, has released its latest research, “Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline” which provides insights into the global oncology pipeline. The re more

• Cervical Cancer – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Cervical Cancer - Pipeline Review, H2 2012', provides an overview of the Cervical Cancer therapeutic pipeline. This report provides information on the therapeutic development for Cervical Cancer, complete with latest updates, and special features on late-stag more

Websites Cervical Cancer